ABT-436

DRUG4 trials

Sponsors

Abbott, AbbVie, National Institute on Alcohol Abuse and Alcoholism (NIAAA), AbbVie (prior sponsor, Abbott)

Conditions

Alcohol AbuseAlcohol DependenceAlcohol Use DisordersAlcoholismHealthyMajor Depressive Disorder

Phase 1

A Study of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Doses of ABT-436 in Healthy Adults

CompletedNCT01050127

Start: 2009-12-31Updated: 2010-11-03

Safety and Pharmacodynamic Study of ABT-436 in Major Depressive Disorder

CompletedNCT01380704

AbbVieMajor Depressive Disorder

Start: 2011-06-30End: 2011-09-30Updated: 2017-11-21

Phase 2

ABT-436 for Alcohol Dependence

CompletedNCT01613014

National Institute on Alcohol Abuse and Alcoholism (NIAAA)Alcohol Abuse, Alcohol Dependence, Alcoholism +1

Start: 2013-02-28End: 2015-07-31Updated: 2017-04-04

Efficacy and Safety Study of ABT-436 in Major Depressive Disorder

TerminatedNCT01741142

AbbVie (prior sponsor, Abbott)Major Depressive Disorder

Start: 2012-01-31End: 2015-08-31Updated: 2013-10-08